FEMY · Femasys Inc
United States · RS rating 49 · As of 2026-10-14
| Price | 1.56 USD |
|---|---|
| 1-day change | -11.4% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 4 / 5 / 98 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 38 / 22 |
| Industry group (rank) | Medical-Systems/Equip (93) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.5% |
| Distance from 52-week high | +71.1% |
| Market cap (USD) | $24.1M |